{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:48:43Z","timestamp":1762325323151,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"],"award-info":[{"award-number":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"],"award-info":[{"award-number":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"]}]},{"name":"\u201cPioneer\u201d and \u201cLeading Goose\u201d R&amp;D Program of Zhejiang","award":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"],"award-info":[{"award-number":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"]}]},{"name":"Science Foundation of Zhejiang Sci-Tech University (ZSTU)","award":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"],"award-info":[{"award-number":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"]}]},{"name":"Fundamental Research Funds of Zhejiang Sci-Tech University","award":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"],"award-info":[{"award-number":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"]}]},{"name":"Open Fund of the Shaoxing Academy of Biomedicine of Zhejiang Sci-Tech University","award":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"],"award-info":[{"award-number":["32172893","LY22C180002","LQ22C180003","2022C02031","20042220-Y","2021Q035","SXAB202019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Influenza virus infects the host and transmits through the respiratory tract (i.e., the mouth and nose); therefore, the development of intranasal influenza vaccines that mimic the natural infection, coupled with an efficient mucosal adjuvant, is an attractive alternative to current parenteral vaccines. However, with the withdrawal of cholera toxin and Escherichia coli heat-labile endotoxin from clinical use due to side effects, there are no approved adjuvants for intranasal vaccines. Therefore, safe and effective mucosal adjuvants are urgently needed. Previously, we reported that one derivative of \u03b1-Galactosylceramide (\u03b1-GalCer), 7DW8-5, could enhance the protective efficacy of split influenza vaccine by injection administration. However, the mucosal adjuvanticity of 7DW8-5 is still unclear. In this study, we found that 7DW8-5 promotes the production of secret IgA antibodies and IgG antibodies and enhances the protective efficacy of the split influenza vaccine by intranasal administration. Furthermore, co-administration of 7DW8-5 with the split influenza vaccine significantly reduces the virus shedding in the upper and lower respiratory tract after lethal challenge. Our results demonstrate that 7DW8-5 is a novel mucosal adjuvant for the split influenza vaccine.<\/jats:p>","DOI":"10.3390\/v14061174","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:25:42Z","timestamp":1653974742000},"page":"1174","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Glycolipid \u03b1-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4889-7609","authenticated-orcid":false,"given":"Huapeng","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruolin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanru","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunfan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruonan","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genzhu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siquan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Life Sciences, China Jiliang University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhong","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","article-title":"Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture","volume":"9","author":"Rajao","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14760584.2016.1142878","article-title":"The Effectiveness of Influenza Vaccination in Different Groups","volume":"15","author":"Dominguez","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: Challenges and solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/14760584.2018.1507743","article-title":"Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics","volume":"17","author":"Sano","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7883\/yoken.JJID.2015.560","article-title":"Intranasal Inactivated Influenza Vaccines: A Reasonable Approach to Improve the Efficacy of Influenza Vaccine?","volume":"69","author":"Tamura","year":"2016","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1016\/j.vaccine.2012.04.109","article-title":"Mucosal IgA responses in influenza virus infections; thoughts for vaccine design","volume":"30","author":"Ainai","year":"2012","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","article-title":"Mucosal vaccine design and delivery","volume":"14","author":"Woodrow","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJMp048006","article-title":"Nasal vaccination, Escherichia coli enterotoxin, and Bell\u2019s palsy","volume":"350","author":"Couch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.1006662107","article-title":"Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2010.11.009","article-title":"Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant","volume":"140","author":"Padte","year":"2011","journal-title":"Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Padte, N.N., Boente-Carrera, M., Andrews, C.D., McManus, J., Grasperge, B.F., Gettie, A., Coelho-dos-Reis, J.G., Li, X., Wu, D., and Bruder, J.T. (2013). A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078407"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3389\/fmicb.2019.02157","article-title":"A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice","volume":"10","author":"Feng","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.vaccine.2009.01.083","article-title":"Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens","volume":"27","author":"Courtney","year":"2009","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1016\/j.vaccine.2007.04.081","article-title":"A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system","volume":"25","author":"Youn","year":"2007","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.vaccine.2009.03.090","article-title":"Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine","volume":"27","author":"Fraser","year":"2009","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virusres.2011.03.022","article-title":"Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice","volume":"158","author":"Sakabe","year":"2011","journal-title":"Virus Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.vaccine.2016.04.001","article-title":"Intranasal hydroxypropyl-beta-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection","volume":"34","author":"Kusakabe","year":"2016","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/am.16.4.588-594.1968","article-title":"Replication and plaque assay of influenza virus in an established line of canine kidney cells","volume":"16","author":"Gaush","year":"1968","journal-title":"Appl. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1016\/j.vaccine.2014.07.079","article-title":"Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine","volume":"32","author":"Uraki","year":"2014","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmicb.2019.00019","article-title":"Injectable Excipients as Novel Influenza Vaccine Adjuvants","volume":"10","author":"Feng","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1016\/j.vaccine.2010.04.011","article-title":"Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine","volume":"28","author":"Samira","year":"2010","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"56147","DOI":"10.18632\/oncotarget.11269","article-title":"OASIS 2: Online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research","volume":"7","author":"Han","year":"2016","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7774\/cevr.2017.6.1.15","article-title":"The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants","volume":"6","author":"Kim","year":"2017","journal-title":"Clin. Exp. Vaccine Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-3083.2005.01633.x","article-title":"Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB\/c mice","volume":"62","author":"Hovden","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41570-020-00244-3","article-title":"Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action","volume":"5","author":"Pifferi","year":"2021","journal-title":"Nat. Rev. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Shirai, S., Kawai, A., Shibuya, M., Munakata, L., Omata, D., Suzuki, R., and Yoshioka, Y. (2020). Lipid Nanoparticle Acts as a Potential Adjuvant for Influenza Split Vaccine without Inducing Inflammatory Responses. Vaccines, 8.","DOI":"10.3390\/vaccines8030433"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.vaccine.2018.04.054","article-title":"A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine","volume":"36","author":"Hjertner","year":"2018","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons","volume":"44","author":"Carroll","year":"2016","journal-title":"Immunity"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1174\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:20:29Z","timestamp":1760138429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,28]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["v14061174"],"URL":"https:\/\/doi.org\/10.3390\/v14061174","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2022,5,28]]}}}